"10.1371_journal.pone.0038273","plos one","2012-06-19T00:00:00Z","Geneviève Derumeaux; Laura Ernande; André Serusclat; Evelyne Servan; Eric Bruckert; Hugues Rousset; Stephen Senn; Luc Van Gaal; Brigitte Picandet; François Gavini; Philippe Moulin; on behalf the REGULATE trial investigators","Echocardiography Laboratory, Hôpital Louis Pradel, Lyon, France; Department of Medical Imaging and Endocrinology, Hôpital Louis Pradel, Lyon, France; Department of Endocrinology and Metabolism, Hôpital Pitié Salpêtrière, Bâtiment Husson Mourier, Paris, France; Internal Medicine, Centre Hospitalier, Pierre Benite, France; Department of Statistics, University of Glasgow, Glasgow, United Kingdom; Department of Diabetology, Metabolism & Clinical Nutrition, Faculty of Medicine, University Hospital Antwerp, Edegem-Antwerp, Belgium; Institut de Recherches Internationales Servier, Courbevoie, France; Endocrinology Department, Hôpital Louis Pradel, Hospices Civils de Lyon, University Lyon1, Lyon, France","Conceived and designed the experiments: GD EB SS LVG BP PM. Analyzed the data: GD EB SS LVG BP FG PM. Wrote the paper: GD PM. Review of the MS: GD LE AS EB HR SS LVG BP FG PM. Assessed the echography and adjudicated the CV events: GD LE AS ES HR. Supervised the statistical analaysis: SS LVG. Echo assessment centralized reading: GD LE ES.","The authors declare the following interests: GD reports receiving honoraria for board membership from: Servier; grants supports paid to her institution from: Astra Zeneca, Actelion, Bayer; Brahms; General Electrics; Medtronic, Pfizer; Servier; Toshiba; Trophos, Travel support for scientific meetings: Actelion; Astra Zeneca, Boehringer Ingelheim, Medtronic; Pfizer, Sanofi, Servier. LE reports receiving honoraria from: Actelion, Daichi Sankyo, Servier; Travel support for scientific meetings: Pfizer, Sanofi, Servier, AS reports receiving honoraria and or travel support for scientific meetings from: Astra Zeneca, BMS, GSK, Lilly; Novartis, Pierre Fabre, Pfizzer, Sanofi, Siemens; grants supports paid to his institution from: Servier; ES reports receiving honoraria from Daichi Sankyo Servier; travel support for scientific meetings: Pfizer, Sanofi, Servier, EB reports receiving fees for presentations and participation to boards: Merck, Pfizer, Astra Zeneca, Abott, California Almond Board, Unilever, Danone, Servier, Sanofi-Avantis, MSD, Shering Plough, Genfit, AMT and NovoNordisk Hugues Rousset reports receiving grants supports paid to his institution from: Servier; SS reports receiving consulting honoraria from: Actelion; Astra-Zeneca, Auxilium; Bayer; BIOP; Biosyn; Biovitrum; Braco; Bristol-Myer Squibb; Boehringer Ingelheim; Chiesi; Chiron; Covance; CROS; Danone; Elan; Ely Lilly; Eisai; Fournier; GlaxoSmithKline; Helsinn; INOT; Jansen; Jerini; Leiras; Merck; Merz; Novartis; Novo-Nordisk; Numico; Organon; Orion; Pfizer; Pharmapart; Pharsight; Phocus; Pleiad; Pozen; Quintiles; Roche; R. W. Johnson; Sanofi; Schein; Schering; Servier; Shire; Stallergenes; Statwood; Strakan; Takeda; UCB; Unilever; Vanda; Wyeth and owning shares in Novartis and Syngenta. LVG reports receiving lecture fees from Eli Lilly and Novo Nordisk and travel reimbursement from Abbott Laboratories, AstraZeneca, Bristol-Myers-Squibb, GlaxoSmithKline, Merck, Novo Nordisk and Sanofi-Aventis and serving on advisory boards for Novo Nordisk, GlaxoSmithKline, AstraZeneca-Bristol-Myers Squibb, Eli Lilly, Merck and Servier. BP and FG report being employees of Servier. PM reports receiving payment for board membership or honoraria for presentation from: AMT, Astra Zeneca, BMS, GSK, NovoNordisk, Lilly; grants supports paid to his institution from: Astra Zeneca, Danone, MSD, Sanofi, Servier; Travel support for scientific meetings: Astra Zeneca, BMS, GSK, Merk Serono, Novartis, Lilly, MSD, Novo Nordisk, Pfizer, Sanofi, Shering Plough, Servier, Takeda. Servier previously marketed benfluorex and Takeda markets pioglitazone. There are no other patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2012","06","Geneviève Derumeaux","GD",12,TRUE,6,NA,7,2,TRUE,TRUE,FALSE,0,NA,FALSE
